Clinical Trials Logo

Clinical Trial Summary

This research uses the Liquid Chromatography coupled to tandem Mass Spectrometry (LC-MS / MS) technique on dried blot spot samples for the neonatal screening of congenital adrenal hyperplasia. The main objective of this study is to demonstrate that this technique allow dosage of adrenal steroids on dried blot spot samples as efficiently and with the same sensitivity than the current technic on a cohort of 132 newborns aged 2 to 5 days, with a gestational age greater than or equal to 30 weeks of amenorrhea.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03589144
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Completed
Phase
Start date February 11, 2019
Completion date April 29, 2020

See also
  Status Clinical Trial Phase
Completed NCT03162172 - Growth Hormone (GH) in Congenital Adrenal Hyperplasia N/A
Recruiting NCT00617292 - Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers N/A
Completed NCT00529841 - Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia N/A
Recruiting NCT05228652 - Questionnaire Study to Assess the Outcomes of the Management of Congenital Adrenal Hyperplasia Individuals
Recruiting NCT01771328 - Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia Phase 2
Active, not recruiting NCT01862380 - Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency. N/A
Completed NCT01488721 - Clinical Evaluation of NeoPlex4 Assay and NeoPlex System N/A
Recruiting NCT00694525 - Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia N/A
Completed NCT00621985 - Dexamethasone Treatment of Congenital Adrenal Hyperplasia Phase 2